Technical Analysis for ACRS - Aclaris Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Crossed Above 20 DMA | Bullish | 0.00% | |
| 20 DMA Resistance | Bearish | 4.55% | |
| Volume Surge | Other | 4.55% | |
| Gapped Up | Strength | 4.55% | |
| Down 3 Days in a Row | Weakness | 4.55% | |
| 50 DMA Resistance | Bearish | 3.60% | |
| Fell Below 20 DMA | Bearish | 3.60% | |
| Fell Below 50 DMA | Bearish | 3.14% | |
| 180 Bearish Setup | Bearish Swing Setup | 3.14% |
| Alert | Time |
|---|---|
| 1.5x Volume Pace | about 5 hours ago |
| Up 2 ATRs | about 6 hours ago |
| Rose Above Previous Day's High | about 6 hours ago |
| Up 10% | about 6 hours ago |
| Up 1 ATR | about 6 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/05/2024
Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.12 |
| 52 Week Low | 0.5902 |
| Average Volume | 877,852 |
| 200-Day Moving Average | 2.12 |
| 50-Day Moving Average | 1.16 |
| 20-Day Moving Average | 1.12 |
| 10-Day Moving Average | 1.16 |
| Average True Range | 0.09 |
| RSI (14) | 50.98 |
| ADX | 17.07 |
| +DI | 26.31 |
| -DI | 17.84 |
| Chandelier Exit (Long, 3 ATRs) | 1.03 |
| Chandelier Exit (Short, 3 ATRs) | 1.25 |
| Upper Bollinger Bands | 1.27 |
| Lower Bollinger Band | 0.97 |
| Percent B (%b) | 0.59 |
| BandWidth | 27.26 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0023 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.41 | ||||
| Resistance 3 (R3) | 1.42 | 1.34 | 1.36 | ||
| Resistance 2 (R2) | 1.34 | 1.28 | 1.34 | 1.35 | |
| Resistance 1 (R1) | 1.25 | 1.24 | 1.30 | 1.24 | 1.33 |
| Pivot Point | 1.17 | 1.17 | 1.20 | 1.17 | 1.17 |
| Support 1 (S1) | 1.08 | 1.11 | 1.13 | 1.07 | 0.97 |
| Support 2 (S2) | 1.00 | 1.07 | 1.00 | 0.95 | |
| Support 3 (S3) | 0.91 | 1.00 | 0.94 | ||
| Support 4 (S4) | 0.90 |
